Login

Tal Yalon, M.D., Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Thyroid & Parathyroid Surgery: Ask Mayo Clinic Health System

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Long-term Investment Strategies Amid Trade Tensions and Economic Shifts in China | Yimei Li, CEO , China Asset Management.
00:10:00
Insight Direkt Interviews Børge Leknes, CEO of Nord InsureTech, on 2021 Highlights | Børge Leknes, CEO, Nord Insuretech Group AB.
00:10:00
Secure Your Future with Expert Financial Guidance | Trent Porter, Financial Advisor & CEO of priority financial partners
00:10:00
Navigating Economic Challenges: Insights from Dr. Peter R. Orszag | Peter Orszag - Chief Executive Officer at Lazard Asset Management
00:10:00
Committed to advancing transformative therapies for people with cancer and rare diseases|MICHAEL SOLOMON,Director,Proteon Pharmaceuticals
00:10:00
Innovation in Investment Management: Unveiling the Jobs to be Done|David Taten,Partner,Teten Advisors, LLC
00:00:00
Jan Adriaan (Arjan) Haverhals Chief Executive Officer and President, Milestone Scientific Inc
00:00:00
Eden Research targets New Zealand wine grape market after receiving regulatory sign-off - Sean Smith, CEO, Eden Research
00:10:00
Cobas AM Fund Performance Review: Second Half of 2023 with Francisco García Paramés and Carlos González Ramos
00:10:00
Strategies for Sustainable Growth in Brazil's Energy Sector | Gustavo Estrella , CEO, CPFL Energia SA.
00:00:00
BerGenBio (BGBIO) is a clinical-stage biopharmaceutical company - Martin Olin , Chief Executive Officer, Bergenbio
00:10:00
Unveiling the Potential: Exploring Vizsla Silver's Panuco Project with CEO Michael Konnert | Michael A. Konnert - President, CEO of Vizsla Silver Corp.

© 2017 - Neuhu+